| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a2977e43e77557f1ce0106ad3afc20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5722d085f7c8907341b34eb1778f162d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d0d7fd69b2e922df026bd532fd3aae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde9c1b46fd5398f7ce8bb67917c0c9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66932ceaf5678a8fbfc4aa55f3259fe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_049b014fc958510e522e20360fc9e922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69b4de7d64ebafc368b849bca94eab18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-0078 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N7-00 |
| filingDate |
2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb98af4346a8c84ae629a21cdc6990d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54405c36e09d191fed83726262e9bcd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fa0912c5e9cba4f398a521feecbb429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06c5a0c5410593624a21a4553ed7ace1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec52d00d4cd0997ea8219f67e551de65 |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012232437-A1 |
| titleOfInvention |
Device for modulating pgc-1 expression, and treating device and treating method for ischemic disease |
| abstract |
A PGC-1 expression-modulating device ( 1 ) according to the present invention includes an ultrasonic wave transmitting section ( 14 ) that irradiates a subject living body with ultrasonic waves. This configuration modulates PGC-1 expression in a living body and promotes angiogenesis in which VEGF is involved. This enables promoting angiogenesis in a living body and treating ischemic disease without an excessive burden on a patient. |
| priorityDate |
2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |